Mounjaro Users in the UK: Who They Are and What to Expect (October 2026)

01 · Core answer

Is Mounjaro relevant to you?

Mounjaro is relevant if you are an adult living with excess weight, or type 2 diabetes, and a prescriber agrees it is appropriate. It is not a cosmetic product or a quick fix. It is a prescription-only medicine used alongside a reduced-calorie diet and increased physical activity.¹

Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes. It comes as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹

That description covers a wide range of people. Some have lived with excess weight for many years and tried repeated diets. Some have a weight-related health condition and have been advised by a clinician to lose weight. Others have type 2 diabetes and take it through their diabetes care. What they share is a prescriber who has reviewed their health history and judged the treatment suitable.

02 · Candidates

Who is a good candidate for Mounjaro?

A good candidate is an adult who meets the licensed criteria, has no reason the prescriber considers a barrier, and is ready to combine the injection with changes to eating and activity. For the NHS pathway, NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition.⁴

Private treatment is reviewed against the licence rather than the NHS thresholds. That is why a free online consultation matters: a GPhC-registered prescriber reviews your answers, not a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.

Good candidates also tend to share practical traits. They can inject once a week on a regular day, they will attend follow-up reviews, and they understand that results vary. They are realistic about the fact that the medicine supports a reduced-calorie diet rather than replacing it. If that sounds like you, the next step is the Mounjaro pen prices and consultation page, where the free consultation starts.

03 · Cost

What does it cost to become a user?

The standard price of the 2.5mg starter pen is £169.99 per month. Every later order is £25 off the standard price (code DOSE25). Across the UK pharmacies we track, starting pens range from £143.96 to £179.99, checked 10 October 2026.

If you step up after 4 weeks on each dose, your first four pens (2.5mg to 10mg) cost £959.96 at standard prices; a new customer's first order is £40 less and every later order £25 less. If you are weighing cost against other options, our guide on how Mounjaro users are swerving the price sets out the legitimate ways people manage it.

Everything else is straightforward: the consultation is free, the price shown is the price paid, and there are no hidden fees. Delivery is free next-day tracked delivery in temperature-controlled packaging, and Saturday delivery is £14.99.

04 · Who uses it

Who uses Mounjaro in the UK?

People using Mounjaro in the UK are adults prescribed tirzepatide for weight management or type 2 diabetes. It is not licensed for any other group.¹

Different routes into treatment

Some people reach Mounjaro through the NHS, where access is being phased in over several years. Others use regulated private treatment, where a free online consultation is reviewed by a GPhC-registered prescriber. A person with type 2 diabetes may be prescribed it as part of diabetes care. These routes share the same medicine and the same pen. What differs is who decides eligibility and who pays.

What users have in common

Most users share a few practical features. They inject once a week, on a day they choose and keep consistent. They start on the lowest strength and step up over time with prescriber guidance. They are asked to pair treatment with a reduced-calorie diet and more physical activity.¹ They also tend to have ongoing contact with a clinical team, which in our service means monthly reviews, dose-titration and follow-up assessments, plus side-effect support.

Who should be cautious

Not everyone is suitable, and that is the reason a prescriber reviews each person. You should not take Mounjaro if you are allergic to tirzepatide or any of its ingredients, and it should not be used during pregnancy or while trying to conceive. Your prescriber will take extra care, or may recommend against treatment, if you have a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy, or gallbladder problems. Your answers about your health, other medicines and circumstances matter, and you should give them fully. If anything changes between orders, tell the prescribing team. Repeat orders re-check suitability, and nothing ships automatically, so there is a built-in point to raise changes.

If you want a food-focused view of daily life as a user, our guide to the best diet for Mounjaro users covers what to put on the plate, and our page on vitamins for Mounjaro users covers supplements people ask about most.

05 · How it works

How Mounjaro works for users

Mounjaro works by acting on two gut-hormone pathways at the same time. The mechanism is well described: tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹

What that means in daily life

In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹ Notice the wording: it supports a diet; it does not do the dieting for you. Users who treat the injection as a tool, and keep building habits around meals, activity and sleep, are using it as intended.

Why it is different from older options

This dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy/Ozempic).¹ That is a statement about mechanism, not a promise that it will work better for you personally. Both are licensed, effective treatments, and a prescriber can help decide between them.

Once a week, not daily

Mounjaro and Wegovy are both once-weekly pens. Liraglutide, supplied as Saxenda and in products such as Erly, comes at a concentration of 6mg per millilitre and is a daily injection. For some users, a weekly routine is simpler to keep. For others, the schedule matters less than how they tolerate each medicine.

Dose steps

Users begin at 2.5mg and move through 5mg, 7.5mg, 10mg and 12.5mg up to 15mg, depending on prescriber guidance and how they respond. Not everyone needs the top strength, and settling at a lower dose is normal.

Why the slow start matters

Starting low and stepping up gives the prescribing team a chance to review how you feel at each stage. If you are curious about what users eat while stepping up, see our page on the best diet for Mounjaro users. Always follow the pen's instructions and the patient information leaflet for how to inject. Needles, a sharps bin and injection guidance are included with every order.

06 · Trial results

What do trials show about Mounjaro users?

In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.²

Read the numbers carefully

These are trial averages — individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.² Trial averages do not predict your own result. Some people will lose more than the average, and some will lose less.

How many reached meaningful loss

At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight. Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.² Those figures describe a research setting with regular support, so treat them as an indication of what is possible rather than a forecast.

A worked example

For someone starting at 100 kg, 20.9% is about 21 kg. That is straight arithmetic on a trial average, not a target and not a timetable.

What about the quick timelines you see online

Those are generalisations. Trial evidence gives averages over a long treatment period, not a promise about any given week. Be wary of any page that promises specific results on a specific schedule.

Comparisons with Wegovy

A direct tirzepatide-versus-semaglutide comparison comes from SURMOUNT-5, the first large head-to-head trial of the two.¹⁵ Numbers from separate trials should not be placed next to each other as if they were head to head. Our own view: both are effective licensed treatments, and the choice is personal and clinical.

07 · NHS and private

NHS or private: how do users get Mounjaro?

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶

What phased access means

Phased means that not everyone who qualifies on paper can be treated immediately. Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.⁶ If you think you may qualify on the NHS, speak to your GP.

The private route, step by step

Ordering privately with us follows the same four stages for everyone. First, a free online consultation: a short health questionnaire, no charge and no obligation. Second, a review by a GPhC-registered prescriber. Third, dispensing by our registered pharmacy, with same-day dispatch when ordered by 3pm. Fourth, free next-day tracked delivery in discreet, temperature-controlled packaging.

What private treatment includes

Ongoing monthly reviews, dose-titration and follow-up assessments by the prescribing team are part of the service, along with side-effect support. Our Mounjaro comes from official LillyDirect supply, direct from Eli Lilly's UK distribution, as genuine KwikPens. All six doses are in stock. You can pay by Visa or Mastercard, use Klarna or pay-monthly options, and there is no subscription.

Cost and the legitimate ways to manage it

Your first 2.5mg pen costs £129.99 with code FIRST40 (standard price £169.99). If you are switching to us at the top strength, your first order is £289.99. Every later order is £25 off the standard price. For wider context, see how users are getting round the exorbitant price and how users are beating the price hike.

Prices checked 10 October 2026. Always buy from a pharmacy you can verify on the GPhC register. Ours is registered under number 9012878.

08 · Staying on or stopping

What happens if users stop Mounjaro?

Stopping is a decision to make with your prescriber, and the medicine leaves your system gradually rather than at once. Tirzepatide has a half-life of about five days, so after a final dose it takes roughly four to five weeks to clear the system — there is no way to speed this up, and nothing needs doing while it clears.¹

Why people stop

People stop for many reasons: cost, side effects, reaching a goal, a change in health, pregnancy planning or simply feeling it is not for them. Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly. The same is true for those who ask why so many people quit Ozempic. What is useful is to treat stopping as a planned conversation, not a sudden gap.

Weight regain and maintenance

In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued treatment lost a further 5.5% on average.¹⁴ Mounjaro manages weight; it does not cure the biology behind it. Stopping should always be planned with your prescriber, with diet and activity habits ready to carry the load.

Planning rather than quitting

If cost is the pressure, speak to the prescribing team before you stop. The reorder discount applies to every future order. Our guides on beating the price rise and how users are getting around common obstacles cover the practical side.

Storing your pens

Once in use, a pen can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use, and must then be thrown away. Unopened pens are kept in the fridge until first use and keep until the printed expiry date. Follow the patient information leaflet.¹³

Support when you are unsure

Our support team is available Monday to Friday, 9am to 5pm, by email at support@everydaymeds.co.uk, through the account portal chat or by phone on 0333 207 0413. The free GLPTrackr app also lets you keep a record of your journey, which is useful to bring to reviews.

09 · Safety and reporting

Is Mounjaro safe, and how are problems reported?

Mounjaro is a licensed prescription medicine, and its safety information sits in the product information rather than in news stories. Every user should read the patient information leaflet and the prescriber's guidance before starting.¹³

Which is safer, Wegovy or Mounjaro?

Neither is simply safer. Both are licensed, regulated prescription medicines with their own product information, and the right choice depends on your health history and how you respond. Your prescriber is the right person to weigh that up with you, and our Wegovy pen page lets you see the alternative.

Pancreatitis and other concerns

Users often ask about specific risks. Our related guide, what percentage of Mounjaro users get pancreatitis, covers this in more detail. If you have severe or persistent stomach pain, get medical help straight away rather than waiting for a review.

Mood and mental health

Regulators have looked specifically at whether GLP-1 medicines are linked to low mood or suicidal thoughts: the EMA's safety committee reviewed the evidence and concluded in 2024 that it does not support a causal link, and the MHRA keeps this under continuous review.¹⁷ That said, any big change in weight, appetite and routine can affect how you feel — tell your prescriber about any history of depression, and seek help promptly if your mood drops or you have distressing thoughts during treatment.

If you have thoughts of harming yourself or ending your life, get help straight away. Call 999 or go to A&E if you are in immediate danger. In England you can call NHS 111 and choose the mental health option, any time. You can also call Samaritans free on 116 123, day or night. Tell your prescriber about any change in your mood while taking Mounjaro.

Media terms: Ozempic teeth, breasts and smell

Phrases such as Ozempic teeth, Ozempic breasts, or being able to smell someone on Ozempic are media labels, not clinical diagnoses. They are not listed as side effects in the UK Mounjaro patient leaflet. If you notice a new symptom of any kind, discuss it with your prescriber and report it through the Yellow Card scheme.¹⁹

Reporting a suspected side effect

You can report any suspected side effect to the MHRA Yellow Card scheme yourself, and reports help regulators spot patterns.⁷ Our prescribing team also offers side-effect support during monthly reviews. Tell us if you notice anything unexpected, and never ignore a symptom because you assume it is normal.

Counterfeits

Fake and unregulated pens exist. The MHRA publishes counterfeit medicine alerts.⁷ Walk away from any seller offering to supply without a consultation or prescription. Check any pharmacy on the GPhC register.¹²

10 · Supplements and nicknames

What is the poor man's Ozempic?

The phrase "poor man's Ozempic", like "nature's Ozempic", is a marketing nickname usually attached to low-cost supplements such as berberine. It is not a medicine, and there is no clinical oversight behind it. These products are available cheaply without assessment, and their dosing is not standardised.

Why the comparison misleads

Mounjaro is a licensed prescription medicine, and Ozempic is semaglutide licensed for type 2 diabetes — it is not a UK weight-loss medicine. Dramatic weight-loss claims on supplement pages should be read as advertising.

If you take supplements anyway

Tell your prescriber about everything you take. Some users add vitamins for general health while on treatment, and our guide to the best vitamins for Mounjaro users explains what people ask and where the evidence stops. Treat supplements as a separate topic from the prescription medicine, not as a substitute or a cheaper copy.

Unregulated sellers

Cost pressure makes people look for shortcuts, and some sellers exploit that. Pens offered without a consultation or prescription are a red flag. The MHRA warns about counterfeit medicines and runs the Yellow Card scheme for reporting problems.⁷ A genuine supplier will review your health first, explain the risks and refund you if the order is unsuitable.

Public figures and personal choices

People often ask why a celebrity stopped a medicine. We do not comment on individuals, and a public figure's choice says little about what will suit you. Personal reasons vary, from cost to side effects to simply having reached a goal. Your own clinical review is a far better guide than a headline.

The sensible shortcut

If cost is the barrier, the legitimate approach is to use new-customer and reorder discounts, and spread payment with Klarna or pay-monthly options. Our weight loss clinic page explains the wider support available, including reviews and the companion app.

11 · GLP-1 users compared

How do GLP-1 users compare across medicines?

GLP-1 users take several different medicines, and Mounjaro is only one of them. Wegovy (semaglutide) is another once-weekly pen, with a dose ladder of 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg, stepping up after at least four weeks and reaching the 2.4mg maintenance dose from week 17.¹⁸ The 2.4mg dose is the licensed maintenance dose for weight management.¹⁸

Mounjaro versus Wegovy users

Mounjaro acts on GIP and GLP-1 receptors, while semaglutide is a single-action medicine.¹ Users often want to know which one suits them. That is a clinical decision, and only a direct trial supports a comparison. Cost also differs, and the current first-order price of a starting Wegovy pen is £99.99. A first Mounjaro 2.5mg pen is £129.99 with code FIRST40.

Daily injections

Liraglutide, supplied as Saxenda and in products such as Erly, is a daily injection at a concentration of 6mg per millilitre. For users who prefer a weekly rhythm, that is a practical difference.

Tablets

Wegovy tablets and Foundayo are oral options. See current Wegovy tablet prices on the product page when you are ready to look.

How to choose

Start with your goals, your health history and your prescriber's view. Consider how you feel about weekly versus daily routines, and how much follow-up support you want. If you decide Mounjaro is the right route, the Mounjaro pen prices and consultation page starts the free online consultation, with no obligation.

One note on switching

If you are switching from another provider, a new customer gets £40 off their first order at any dose with code FIRST40. Tell the prescriber your current dose and how you have been feeling so the review can place you appropriately. Do not guess a starting strength yourself.

12 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹